#btk inhibitor
2 stories
FDA approves Jaypirca for untreated blood cancers
The drug pirtobrutinib gains approval for first-time treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma in patients without a 17p deletion.
WebMD · 1m
Managing blood cancer treatment with zanubrutinib
A complete guide to supportive care strategies that maximize safety and effectiveness during zanubrutinib therapy.
Wellbeing Magazine · 2m